BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03051659-completion@plaintrial.com
DTSTAMP:20261030T135720Z
DTSTART;VALUE=DATE:20230905
SUMMARY:A Randomized Phase II Study Of Eribulin Mesylate With or Without Pe
 mbrolizumab For Metastatic Hormone Receptor Positive Breast Cancer — est
 imated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03051659
URL:https://plaintrial.com/trial/NCT03051659
END:VEVENT
END:VCALENDAR